Phenotypic variability of syndromic craniosynostosis caused by c.833G > T in FGFR2: Clinical and genetic evaluation of eight patients from a five-generation family

Mol Genet Genomic Med. 2022 Apr;10(4):e1901. doi: 10.1002/mgg3.1901. Epub 2022 Mar 2.

Abstract

Objective: Craniosynostosis is the result of the early fusion of cranial sutures. Syndromic craniosynostosis includes but not limited by Crouzon syndrome and Pfeiffer syndrome. Considerable phenotypic overlap exists among these syndromes and mutations in FGFR2 may cause different syndromes. This study aims to investigate the explanation of the phenotypic variability via clinical and genetic evaluation for eight patients in a large pedigree.

Methods: For each patient, comprehensive physical examination, cranial plain CT scan with three-dimensional CT reconstruction (3D-CT), and eye examinations were conducted. Whole exome sequencing was applied for genetic diagnosis of the proband. Variants were analyzed and interpreted following the ACMG/AMP guidelines. Sanger sequencing was performed to reveal genotypes of all the family members.

Results: A pathogenic variant in the FGFR2 gene, c.833G > T (p.C278F), was identified and proved to be co-segregate with the disease. Some symptoms of head, hearing, vision, mouth, teeth expressed differently by affected individuals. Nonetheless, all the eight patients manifested core symptoms of Crouzon syndrome without abnormality in the limbs, which could exclude diagnosis of Pfeiffer syndrome.

Conclusion: We have established clinical and genetic diagnosis of Crouzon syndrome for eight patients in a five-generation Chinese family. Variability of clinical features among these familial patients was slighter than that in previously reported sporadic cases.

Keywords: FGFR2; Crouzon syndrome; craniosynostosis.

MeSH terms

  • Acrocephalosyndactylia* / genetics
  • Biological Variation, Population
  • Craniofacial Dysostosis* / genetics
  • Craniosynostoses* / genetics
  • Humans
  • Receptor, Fibroblast Growth Factor, Type 2* / genetics
  • Syndrome

Substances

  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2